Report highlights high cost of specialty drugs

04/27/2012 | Modern Healthcare (subscription required)

Specialty-drug makers have "near-monopoly pricing power," and most of these drugs are covered under medical insurance plans, not pharmacy benefit plans, a study found. "The division of benefit structures makes management of specialty drugs more complex and challenging for payers," the study authors wrote.

View Full Article in:

Modern Healthcare (subscription required)